Preimplantation Genetic Diagnosis (PGD)

What is Preimplantation Genetic Diagnosis (PGD)?

Genetic testing of embryos has become the most important part of IVF treatments in recent years. The aim is to find a healthy embryo by genetic examination of the cell sample taken from the embryos.

Genetic diagnosis is mostly applied in single gene diseases (such as cystic fibrosis, sickle cell anemia) as well as structural chromosome disorders. This increases the likelihood of a healthy pregnancy and the rate of taking a baby home.

Does Preimplantation Genetic Diagnosis Harm the Embryo?

Clinical studies show that taking a biopsy from the embryo with PGD does not affect the embryo's ability to attach, but it does affect embryo viability.

Does Preimplantation Genetic Diagnosis Cause Congenital Problems?

Any congenital problems in children born with PGD are no different from those in pregnant women who conceive normally.

To whom is Preimplantation Genetic Diagnosis applied?

PGD can be applied in in vitro fertilization treatments. But the most common group to benefit;

• Gender-related genetic disorders
• Single gene disorders
• Structural chromosome disorders.

In addition to all these disorders;

• Women over 38 years of age are more likely to have abnormal embryos. These disorders are detected with the test known as PGT-A.
• It is applied in couples with recurrent pregnancy loss or recurrent IVF failure.